Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Long-term risk of malignancies in persons with ischemic heart disease treated with trimetazidine dihydrochloride Journal:Communications Medicine | 25-Mar-2025 | ||
Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation
Journal:Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease | 30-Sep-2025 |
